G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript May 1, 2024 G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.19. GTHX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
Explore key financial outcomes, strategic developments, and expert insights from G1 Therapeutics' first quarter of 2024 earnings call.
Q1 2024 G1 Therapeutics Inc Earnings Call